Bluejay Diagnostics (BJDX) Share-based Compensation (2020 - 2025)
Bluejay Diagnostics (BJDX) posted Share-based Compensation of $74.0 for Q4 2025, down 59.56% sequentially from $183.0 in Q3 2025, and up 100.03% YoY from $37.0 in Q4 2024.
Bluejay Diagnostics (BJDX) Share-based Compensation (2020 - 2025) Analysis & Trends
Bluejay Diagnostics has reported Share-based Compensation for 6 years, with the latest figure at $74.0 in Q4 2025.
- Quarterly Share-based Compensation rose 100.03% year-over-year to $74.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.0 (up 100.0% YoY) and the FY2025 annual result came in at $6.0, down 99.97% from the prior year.
- Share-based Compensation slipped to $74.0 in Q4 2025 per BJDX's latest filing, from $183.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $126086.0 in Q1 2022 and troughed at -$287469.0 in Q4 2024.
- A 5-year average of $6544.6 and a median of $5401.0 in 2024 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2022 and 2023: Share-based Compensation surged 76781.71% in 2022, then slumped 266.39% in 2023.
- Over 5 years, Share-based Compensation stood at $21634.0 in 2021, then jumped by 304.85% to $87586.0 in 2022, then plunged by 266.39% to -$145732.0 in 2023, then tumbled by 97.26% to -$287469.0 in 2024, then jumped by 100.03% to $74.0 in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods registered $74.0, $183.0, and -$1563.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Bluejay Diagnostics | 1.91 Mn | 1.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74.00 |
| Dec 31, 2025 | 74.00 |
| Sep 30, 2025 | 183.00 |
| Sep 30, 2025 | 183.00 |
| Jun 30, 2025 | -1,563.00 |
| Jun 30, 2025 | -1,563.00 |
| Mar 31, 2025 | 1,312.00 |
| Mar 31, 2025 | 1,312.00 |
| Dec 31, 2024 | -287,469.00 |
| Dec 31, 2024 | -287,469.00 |
| Sep 30, 2024 | 4,792.00 |
| Sep 30, 2024 | 4,792.00 |
| Jun 30, 2024 | 6,010.00 |
| Jun 30, 2024 | 6,010.00 |
| Mar 31, 2024 | 11,874.00 |
| Mar 31, 2024 | 11,874.00 |
| Dec 31, 2023 | -145,732.00 |
| Dec 31, 2023 | -145,732.00 |
| Sep 30, 2023 | -42,482.00 |
| Sep 30, 2023 | -42,482.00 |